Mannatech (NASDAQ:MTEX) Earns Buy Rating from Analysts at StockNews.com

Analysts at StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX) in a research report issued on Friday. The firm set a “buy” rating on the stock.

Mannatech Stock Up 0.1 %

Shares of NASDAQ MTEX opened at $11.00 on Friday. The company has a current ratio of 1.25, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $20.67 million, a PE ratio of -13.58 and a beta of 1.02. The stock’s fifty day simple moving average is $12.30 and its two-hundred day simple moving average is $9.32. Mannatech has a 12-month low of $6.75 and a 12-month high of $16.49.

Mannatech (NASDAQ:MTEX) last issued its quarterly earnings data on Tuesday, November 12th. The company reported ($0.17) EPS for the quarter. Mannatech had a negative net margin of 1.26% and a negative return on equity of 15.62%. The business had revenue of $31.73 million for the quarter.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.